Quest Diagnostics 2015 Annual Report Download - page 13

9
Table 12 - Sample Collaborations
Collaborator Collaboration
Inovalon
Data DiagnosticsTM, a tool that provides real-time patient-specific data analysis that
clinicians can order at the point of care to identify and address gaps in quality, risk,
utilization and medical history insights.
Inserm, the French National
Institute of Health and
Medical Research
BRCA ShareTM a novel data share initiative to provide scientists and laboratory
organizations around the world with open access to BRCA1 and BRCA2 genetic
data.
Perinatal Quality Foundation The national initiative to advance clinically appropriate noninvasive prenatal
screening.
University of California, San Francisco,
the nation's leading university focused
exclusively on health
To accelerate the translation of biomedical research into advanced diagnostics in
the field of precision medicine. This collaboration has the overarching aim of
enabling holistic and integrated diagnostic solutions that close gaps in care or
enable new clinical value, with initial focus areas including autism, oncology,
neurology and women's health.
U.S. Centers for Disease Control and
Prevention ("CDC")
To improve public health analysis of hepatitis C screening, diagnosis and treatment,
based on analysis of our database of national hepatitis C virus ("HCV") diagnostic
information.
National Institutes of Health We participate in studies they sponsor (e.g., NIH National Children Study).
Memorial Sloan Kettering Cancer
Center Our OncoVantageTM solid tumor mutation testing services.
Quintiles Transnational Holdings Inc. Joint venture to provide central laboratory testing services for clinical trials.
Medical and Scientific Expertise. Our medical and scientific experts publish research that demonstrates the clinical
value and importance of diagnostic testing, including in connection with our research and development efforts. Our Quest
Diagnostics Drug Testing IndexTM, which is a periodic report of trends derived from our aggregate drug testing results, is cited
by employers, the federal government and the media to help identify and quantify drug abuse among the nation's workforce.
The table below provides a further sample of the activities of our scientific and medical experts.
Table 13 - 2015 Medical and Scientific
Authored more than 150 publications,
including approximately 100 articles in peer-
reviewed journals
Insights into diagnostic testing; introduce novel diagnostic
approaches; provide latest thinking in lab testing and disease diagnosis
- Addressed such topics as cervical cancer screening, ion mobility
testing and cardiovascular disease, genetic testing for breast cancer risk
and non-invasive prenatal testing.
Authored textbooks or chapters Used by academic institutions to train healthcare providers
Participated on scientific committees
determining guidelines for diagnostic usage Fields include HIV, HCV and testosterone testing
Published Quest Diagnostics Health TrendsTM
reports
Identify trends in disease and wellness.
- Recent reports focused on prescription drug misuse, cervical
disease and diabetes
Health Information Technology Solutions. We have a history of providing leading information technology for
diagnostic information services, including solutions that help healthcare organizations and clinicians enter, share and access
clinical information without costly information technology implementation or significant workflow disruption, and technology
solutions to enable patients to manage their healthcare and medical information. Examples of this include our Care360®
products, national Care 360® healthcare provider network and MyQuest® by Care360® patient healthcare portal, which allows
QUEST DIAGNOSTICS 2015 ANNUAL REPORT ON FORM 10-K